SEARCH

SEARCH BY CITATION

References

  • 1
    Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767811.
  • 2
    Caux C, Dezutter-Dambuyant C, Schmitt D et al. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258261.
  • 3
    Caux C, Massacrier C, Vanbervliet B et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha, II: functional analysis. Blood 1997; 90: 14581470.
  • 4
    Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and down regulated by tumor necrosis factorα. J Exp Med 1994; 179: 11091118.
  • 5
    Blom B, Ho S, Antonenko S et al. Generation of inter-feron alpha-producing predendritic cell (Pre-DC)2 from human CD34+ hematopoietic stem cells. J Exp Med 2000; 192: 17851796.
  • 6
    Reid CDL, Stackpoole A, Meager A et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bi-potent CD34 progenitors in human bone marrow. J Immunol 1992; 149: 26812688.
  • 7
    Young JW, Szabolcs P, Moore MAS. Identification of dendritic cell colony-forming units among normal humanCD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J Exp Med 1995; 182: 11111120.
  • 8
    Randolph GJ, Beaulieu S, Lebecque S et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480483.
  • 9
    Hogan CJ, Shpall EJ, McNulty O et al. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice: multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. Blood 1997; 90: 8596.
  • 10
    Shultz LD, Schweitzer PA, Christianson SW et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180191.
  • 11
    Palucka AK, Gatlin J, Blanck JP et al. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 2003; 102: 33023310.
  • 12
    Nobuyoshi M, Kusunoki Y, Seyama T et al. Arrest of human dendritic cells at the CD34/CD4+/HLA-DR+ stage in the bone marrow of NOD/SCID-human chimeric mice. Blood 2001; 97: 36553657.
  • 13
    Olweus J, Bitmansour A, Warnke R et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 1997; 94: 125512556.
  • 14
    Dzionek A, Fuchs A, Schmidt P et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 60376046.
  • 15
    Evans JT, Cravens P, Lipsky PE et al. Differentiation and expansion of lentivirus vector-marked dendritic cells derived from human CD34+ cells. Hum Gene Ther 2000; 11: 24832492.
  • 16
    Gatlin J, Padgett A, Melkus M W et al. Long-termengraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector. Hum Gene Ther 2001; 12: 10791089.
  • 17
    O'Doherty U, Peng M, Gezelter S et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487493.
  • 18
    Thomas R, Lipsky P E. Human peripheral blood dendritic cell subsets, isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994; 153: 40164028.
  • 19
    Cui Y, Golob J, Kelleher E et al. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 2002; 99: 399408.
  • 20
    Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993; 150: 821834.
  • 21
    Caux C, Vanbervliet B, Massacrier C et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α. J Exp Med 1996; 184: 695706.
  • 22
    Kerre TC, De Smet G, De Smedt M et al. Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells. Blood 2002; 99: 16201626.
  • 23
    Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001; 167: 18621866.
  • 24
    Dzionek A, Sohma Y, Nagafune J et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001; 194: 18231834.
  • 25
    Hesse DG, Tracey KJ, Fong Yetal. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988; 166: 147153.
  • 26
    Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993; 187: 403416.
  • 27
    Kiani A, Tschiersch A, Gaboriau Eetal. Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients. Blood 1997; 90: 16731683.
  • 28
    de Saint-Vis B, Fugier-Vivier I, Massacrier C et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998; 160: 16661676.
  • 29
    Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 11831186.
  • 30
    Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863869.
  • 31
    Sallusto F, Cella MD Anielicetal. Dendritic cell susemac-ropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389400.
  • 32
    Brenchley JM, Douek DC, Ambrozak DR et al. Expansion of activated human naive T-cells precedes effector function. Clin Exp Immunol 2002; 130: 432440.
  • 33
    Enk AA, Angeloni VL, Udey MC et al. An essential role for Langerhans-cell-derived IL-1β in the intiation of primary immune responses of the skin. J Immunol 1993; 150: 36983704.
  • 34
    Ingulli E, Mondino A, Khoruts A et al. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp Med 1997; 185: 21332141.
  • 35
    Foerster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 2333.
  • 36
    Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 12491255.
  • 37
    Gunn MD, Kyuwa S, Tam Cetal. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189: 451460.
  • 38
    Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 1999; 96: 10361041.
  • 39
    Randolph GJ, Inaba K, Robbiani DF et al. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999; 11: 753761.
  • 40
    Cook DN, Prosser DM, Forster R et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000; 12: 495503.
  • 41
    Moser M, Murphy K M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1: 199205.
  • 42
    Schnare M, Barton GM, Holt AC et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947950.
  • 43
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 10331036.
  • 44
    Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 31353142.
  • 45
    Lore K, Betts MR, Brenchley JM et al. Toll-like receptor ligands modulate dendritic cells to augment cytomega-lovirus- and HIV-1-specific T cell responses. J Immunol 2003; 171: 43204328.
  • 46
    Ito T, Amakawa R, Kaisho T et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002; 195: 15071512.
  • 47
    Kohrgruber N, Halanek N, Groger M et al. Survival, maturation, and function of CD11c and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999; 163: 32503259.
  • 48
    Traggiai E, Chicha L, Mazzucchelli L et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104107.